Prediction of glycan motifs using quantitative analysis of multi-lectin binding: Motifs on MUC1 produced by cultured pancreatic cancer cells

Proteomics - Clinical Applications

Volumn 7, Issue 9-10, 2013, Pages 632-641

  Mccarter, Calvin ^a   Kletter, Doron ^b   Tang, Huiyuan ^a   Partyka, Katie ^a   Ma, Yinjiao ^a,c   Singh, Sudhir ^a   Yadav, Jessica ^a   Bern, Marshall ^b   Haab, Brian B ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b PALO ALTO RESEARCH CENTER   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Glycan motif; Glycoforms; Lectins

Indexed keywords

GLYCAN; LECTIN; MUCIN 1; POLYSACCHARIDE; PROTEIN BINDING;

ACCURACY; ARTICLE; CANCER CELL CULTURE; CARBOHYDRATE ANALYSIS; CELL LYSATE; CONTROLLED STUDY; LECTIN BINDING; MESENCHYME CELL; PANCREAS CANCER; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; BIOSYNTHESIS; CHEMISTRY; HUMAN; METABOLISM; MICROARRAY ANALYSIS; PANCREAS TUMOR; PATHOLOGY; PROCEDURES; TUMOR CELL LINE;

CELL LINE, TUMOR; HUMANS; LECTINS; MICROARRAY ANALYSIS; MUCIN-1; PANCREATIC NEOPLASMS; POLYSACCHARIDES; PROTEIN BINDING;

EID: 84885913749     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201300069     Document Type: Article

References (43)

1. Perou, C. M., Sorlie, T., Eisen, M. B., van de Rijn, M. et al., Molecular portraits of human breast tumours. Nature 2000, 406, 747-752.
2. Ransohoff, D. F., The process to discover and develop biomarkers for cancer: a work in progress. J. Nat. Cancer Inst. 2008, 100, 1419-1420.
3. Dube, D. H., Bertozzi, C. R., Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat. Rev. Drug Discov. 2005, 4, 477-488.
4. Moremen, K. W., Tiemeyer, M., Nairn, A. V., Vertebrate protein glycosylation: diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 2012, 13, 448-462.
5. Fuster, M. M., Esko, J. D., The sweet and sour of cancer: glycans as novel therapeutic targets. Nat. Rev. Cancer 2005, 5, 526-542.
6. Lau, K. S., Dennis, J. W., N-Glycans in cancer progression. Glycobiology 2008, 18, 750-760.
7. McGowan, E. D., Bowman, K., Background Paper on Glycosciences and Glycomics in the United States. National Academy of Sciences, National Research Council. 2011.
8. Chen, S., LaRoche, T., Hamelinck, D., Bergsma, D. et al., Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat. Methods 2007, 4, 437-444.
9. Yue, T., Goldstein, I. J., Hollingsworth, M. A., Kaul, K. et al., The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibody-lectin sandwich arrays. Mol. Cell. Proteomics 2009, 8, 1697-1707.
10. Haab, B. B., Porter, A., Yue, T., Li, L. et al., Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann. Surg. 2010, 251, 937-945.
11. Yue, T., Maupin, K. A., Fallon, B., Li, L. et al., Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. PLoS ONE 2011, 6, e29180.
12. Kreunin, P., Zhao, J., Rosser, C., Urquidi, V. et al., Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J. Proteome Res. 2007, 6, 2631-2639.
13. Li, C., Simeone, D., Brenner, D., Anderson, M. A. et al., Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J. Proteome Res. 2009, 8, 483-492.
14. Li, Y., Tao, S. C., Bova, G. S., Liu, A. Y. et al., Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays. Anal. Chem. 2011, 83, 8509-8516.
15. Tabares, G., Radcliffe, C. M., Barrabes, S., Ramirez, M. et al., Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology 2006, 16, 132-145.
16. Wang, M., Long, R. E., Comunale, M. A., Junaidi, O., et al., Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 1914-1921.
17. Aoyagi, Y., Mita, Y., Suda, T., Kawai, K. et al., The fucosylation index of serum alpha-fetoprotein as useful prognostic factor in patients with hepatocellular carcinoma in special reference to chronological changes. Hepatol. Res. 2002, 23, 287.
18. Thompson, S., Cantwell, B. M., Cornell, C., Turner, G. A., Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis. Br. J. Cancer 1991, 64, 386-390.
19. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T. et al., Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 2006, 118, 2803-2808.
20. Hirabayashi, J., Lectin-based structural glycomics: glycoproteomics and glycan profiling. Glycoconj. J. 2004, 21, 35-40.
21. Sharon, N., Lectins : carbohydrate-specific reagents and biological recognition molecules. J. Biol. Chem. 2007, 282, 2753-2764.
22. Van Damme, E. J. M., Peumans, W. J., Pusztai, A., Bardocz, S., Handbook of Plant Lectins: Properties and Biomedical Applications, John Wiley & Sons, Chichester 1998.
23. Markiv, A., Peiris, D., Curley, G. P., Odell, M., Dwek, M. V., Identification, cloning, and characterization of two N-acetylgalactosamine-binding lectins from the albumen gland of Helix pomatia. J. Biol. Chem. 2011, 286, 20260-20266.
24. Porter, A., Yue, T., Heeringa, L., Day, S. et al., A motif-based analysis of glycan array data to determine the specificities of glycan-binding proteins. Glycobiology 2010, 20, 369-380.
25. Maupin, K. A., Liden, D., Haab, B. B., The fine specificity of mannose-binding and galactose-binding lectins revealed using outlier-motif analysis of glycan array data. Glycobiology 2011, 22, 160-169.
26. Kletter, D., Singh, S., Bern, M., Haab, B. B., Global comparisons of lectin-glycan interactions using a database of analyzed glycan array data. Mol. Cell. Proteomics 2013, 12, 1026-1035.
27. Forrester, S., Kuick, R., Hung, K. E., Kucherlapati, R., Haab, B. B., Low-volume, high-throughput sandwich immunoassays for profiling plasma proteins in mice: identification of early-stage systemic inflammation in a mouse model of intestinal cancer. Mol. Oncol. 2007, 1, 216-225.
28. Haab, B. B., Yue, T., High-throughput studies of protein glycoforms using antibody-lectin sandwich arrays. Methods Mol. Biol. 2011, 785, 223-236.
29. Liang, P. H., Wu, C. Y., Greenberg, W. A., Wong, C. H., Glycan arrays: biological and medical applications. Curr. Opin. Chem. Biol. 2008, 12, 86-92.
30. Blixt, O., Head, S., Mondala, T., Scanlan, C. et al., Printed covalent glycan array for ligand profiling of diverse glycan binding proteins. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 17033-17038.
31. Hollingsworth, M. A., Swanson, B. J., Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 2004, 4, 45-60.
32. Moniaux, N., Andrianifahanana, M., Brand, R. E., Batra, S. K., Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br. J. Cancer 2004, 91, 1633-1638.
33. Wu, Y. M., Nowack, D. D., Omenn, G. S., Haab, B. B., Mucin glycosylation is altered by pro-inflammatory signaling in pancreatic-cancer cells. J. Proteome Res. 2009, 8, 1876-1886.
34. Arumugam, T., Ramachandran, V., Fournier, K. F., Wang, H. et al., Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009, 69, 5820-5828.
35. Maupin, K., Sinha, A., Eugster, E., Miller, J. et al., Glycogene Expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems. PLoS ONE 2010, 5, e13002.
36. Collisson, E. A., Sadanandam, A., Olson, P., Gibb, W. J. et al., Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat. Med. 2011, 17, 500-503.
37. Astronomo, R. D., Burton, D. R., Carbohydrate vaccines: developing sweet solutions to sticky situations? Nat. Rev. Drug Discov. 2010, 9, 308-324.
38. Pilobello, K. T., Krishnamoorthy, L., Slawek, D., Mahal, L. K., Development of a lectin microarray for the rapid analysis of protein glycopatterns. Chembiochem 2005, 6, 985-989.
39. Kuno, A., Uchiyama, N., Koseki-Kuno, S., Ebe, Y. et al., Evanescent-field fluorescence-assisted lectin microarray: a new strategy for glycan profiling. Nat. Methods 2005, 2, 851-856.
40. Kletter, D., Cao, Z., Bern, M., Haab, B., Determining Lectin Specificity from Glycan Array Data using Motif Segregation and GlycoSearch Software. Curr. Protoc. Chem. Biol. 2013, 5, 1-13.
41. Hizukuri, Y., Yamanishi, Y., Nakamura, O., Yagi, F. et al., Extraction of leukemia specific glycan motifs in humans by computational glycomics. Carbohydr. Res. 2005, 340, 2270-2278.
42. Xuan, P., Zhang, Y., Tzeng, T. R., Wan, X. F., Luo, F., A quantitative structure-activity relationship (QSAR) study on glycan array data to determine the specificities of glycan-binding proteins. Glycobiology 2012, 22, 552-560.
43. Cholleti, S. R., Agravat, S., Morris, T., Saltz, J. H. et al., Automated motif discovery from glycan array data. OMICS 2012, 16, 497-512.